Glutamic Acid

Glutamic Acid

SCHEMBL2593247

N[C@@H](CCC(=O)O)C(=O)O.O=CCCCC=O

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 2/20 0.69
GRM6 O15303 2/20 0.69
GRM7 Q14831 2/20 0.69
GRM4 Q14833 2/20 0.69
GSR P00390 2/20 0.69
GRIN2D O15399 1/20 0.69
GRIN3B O60391 1/20 0.69
CYP1A2 P05177 1/20 0.69
GRIK1 P39086 1/20 0.69
GRM5 P41594 1/20 0.69
GRIA1 P42261 1/20 0.69
GRIA2 P42262 1/20 0.69
GRIA3 P42263 1/20 0.69
SLC1A3 P43003 1/20 0.69
SLC1A2 P43004 1/20 0.69
SLC1A1 P43005 1/20 0.69
GRIA4 P48058 1/20 0.69
GRIN1 Q05586 1/20 0.69
GRIN2A Q12879 1/20 0.69
GRIK2 Q13002 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
D-Glutamate SCHEMBL9474068 1.00 GRM8 (0.69) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL1469787 0.94 GRM8 (0.67) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL1470464 0.90 GRM8 (0.72) GRM8GRM6GRM7GRM4GSR
Glutamic Acid SCHEMBL31507089 0.85 GRM8 (0.95) GRM8GRM6GRM7GRM4GSR
Glutamic Acid SCHEMBL7294273 0.85 GRM8 (0.95) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL28296939 0.85 GRM8 (0.95) GRM8GRM6GRM7GRM4GSR
D-Glutamate SCHEMBL7294270 0.85 GRM8 (0.95) GRM8GRM6GRM7GRM4GSR
Glutamic Acid SCHEMBL30195410 0.84 GRM8 (0.75) GRM8GRM6GRM7GRM4GSR
SCHEMBL2722969 0.84 GSR (0.56) GRM8GRM6GRM7GRM4GSR
SCHEMBL198242 0.84 GSR (0.56) GRM8GRM6GRM7GRM4GSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130190788-A1 METHODS AND COMPOSITIONS FOR REPAIR OF VASCULAR TISSUE COVALENT MEDICALS INC (US) 2013-07-25 US disclosed
US-8252747-B2 Tissue adhesive sealant LOWINGER JOHAN (US) 2012-08-28 US disclosed
WO-2011139781-A2 METHODS AND COMPOSITIONS FOR REPAIR OF VASCULAR TISSUE COVALENT MEDICAL, INC. (US) 2011-11-10 WO disclosed
US-20090287313-A1 TISSUE ADHESIVE SEALANT LOWINGER JOHAN 2009-11-19 US disclosed
US-7129210-B2 Tissue adhesive sealant COVALENT MEDICAL, INC. (US) 2006-10-31 US disclosed
EP-1651038-A2 TISSUE ADHESIVE SEALANT Covalent Medical, Inc. (US) 2006-05-03 EP disclosed
US-20050069589-A1 Tissue adhesive sealant COVALENT MEDICAL, INC. 2005-03-31 US disclosed
WO-2005009225-A2 TISSUE ADHESIVE SEALANT COVALENT MEDICAL, INC. (US) 2005-02-03 WO disclosed
US-5188834-A Fixing with aldehyde, treating with aminodicarboxylic acid in buffered acidic solution to bind excess aldehyde SORIN BIOMEDICA S.P.A. (IT) 1993-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050069589-A1 Tissue adhesive sealant ICAM1, VCAM1, PLOD3 GRM8 650/4885GRM6 945/4885GRM7 854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.